As shown in Fig. 2d, FAK/SFK inhibitors effectively suppressed the expression of pACLY Tyr542 and Tyr652 and pALDOA Tyr174, Tyr302, and Tyr328 in primary and metastatic ESCC cells. The gene discussed is PTK2; the disease is esophageal squamous cell carcinoma.